Abivax S.A. (ABVX) delivered a return of 1259.43% over the past year. Since ABVX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Abivax S.A. one year ago would be worth $135,943 today, representing a gain of $125,943.

Abivax S.A. (ABVX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ABVX, the total return equals the price-only return.

Yes, Abivax S.A. (ABVX) outperformed the S&P 500 by 1236.75 percentage points over the past year. ABVX delivered a total return of 1259.43%, compared to the S&P 500's 22.68%. This 1236.75pp alpha means investors in ABVX earned more than a passive S&P 500 index fund.

Abivax S.A. (ABVX) experienced a maximum drawdown of -50.11% over the past year, declining from its peak on 2025-12-24 to its trough on 2026-06-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Abivax S.A. (ABVX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 1115.3% (28.4% CAGR) — $10,000 would have grown to $121,530. Over 20 years: 1115.3% total return (13.3% CAGR) — $10,000 → $121,530. Over 30 years: 1115.3% total return (8.7% CAGR) — $10,000 → $121,529. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Abivax S.A.'s best calendar year was 2025 with a total return of 1749.9%. Its worst year was 2024 with a total return of -32.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 1782.1 percentage points.